PresentationGreat. And it has really been a landmark year for Insmed. I have to say a first in disease FDA approval and very strong launch and impressive data in PAH and then really more to comment. I'll pass it to you to give an audience of what's going on at Insmed and what have kept you really busy for the past year.William LewisPresident, CEO & Chairman Yes. It's been an interesting last 18 months for sure. But as we like to point out, we're facing an even more eventful next 18 months because we've just ...